Index
1 Retinal Drugs and Biologics Market Overview
1.1 Product Overview and Scope of Retinal Drugs and Biologics
1.2 Retinal Drugs and Biologics Segment by Type
1.2.1 Global Retinal Drugs and Biologics Market Value Comparison by Type (2024-2030)
1.2.2 Age Related Macular Degeneration
1.2.3 Diabetic Retinopathy
1.2.4 Ocular Inflammatory Disease (Uveitis)
1.2.5 Macular Hole
1.3 Retinal Drugs and Biologics Segment by Application
1.3.1 Global Retinal Drugs and Biologics Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Retinal Drugs and Biologics Market Size Estimates and Forecasts
1.4.1 Global Retinal Drugs and Biologics Revenue 2019-2030
1.4.2 Global Retinal Drugs and Biologics Sales 2019-2030
1.4.3 Global Retinal Drugs and Biologics Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Retinal Drugs and Biologics Market Competition by Manufacturers
2.1 Global Retinal Drugs and Biologics Sales Market Share by Manufacturers (2019-2024)
2.2 Global Retinal Drugs and Biologics Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Retinal Drugs and Biologics Average Price by Manufacturers (2019-2024)
2.4 Global Retinal Drugs and Biologics Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Retinal Drugs and Biologics, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Retinal Drugs and Biologics, Product Type & Application
2.7 Retinal Drugs and Biologics Market Competitive Situation and Trends
2.7.1 Retinal Drugs and Biologics Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Retinal Drugs and Biologics Players Market Share by Revenue
2.7.3 Global Retinal Drugs and Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Retinal Drugs and Biologics Retrospective Market Scenario by Region
3.1 Global Retinal Drugs and Biologics Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Retinal Drugs and Biologics Global Retinal Drugs and Biologics Sales by Region: 2019-2030
3.2.1 Global Retinal Drugs and Biologics Sales by Region: 2019-2024
3.2.2 Global Retinal Drugs and Biologics Sales by Region: 2025-2030
3.3 Global Retinal Drugs and Biologics Global Retinal Drugs and Biologics Revenue by Region: 2019-2030
3.3.1 Global Retinal Drugs and Biologics Revenue by Region: 2019-2024
3.3.2 Global Retinal Drugs and Biologics Revenue by Region: 2025-2030
3.4 North America Retinal Drugs and Biologics Market Facts & Figures by Country
3.4.1 North America Retinal Drugs and Biologics Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Retinal Drugs and Biologics Sales by Country (2019-2030)
3.4.3 North America Retinal Drugs and Biologics Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Retinal Drugs and Biologics Market Facts & Figures by Country
3.5.1 Europe Retinal Drugs and Biologics Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Retinal Drugs and Biologics Sales by Country (2019-2030)
3.5.3 Europe Retinal Drugs and Biologics Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Retinal Drugs and Biologics Market Facts & Figures by Country
3.6.1 Asia Pacific Retinal Drugs and Biologics Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Retinal Drugs and Biologics Sales by Country (2019-2030)
3.6.3 Asia Pacific Retinal Drugs and Biologics Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Retinal Drugs and Biologics Market Facts & Figures by Country
3.7.1 Latin America Retinal Drugs and Biologics Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Retinal Drugs and Biologics Sales by Country (2019-2030)
3.7.3 Latin America Retinal Drugs and Biologics Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Retinal Drugs and Biologics Market Facts & Figures by Country
3.8.1 Middle East and Africa Retinal Drugs and Biologics Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Retinal Drugs and Biologics Sales by Country (2019-2030)
3.8.3 Middle East and Africa Retinal Drugs and Biologics Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Retinal Drugs and Biologics Sales by Type (2019-2030)
4.1.1 Global Retinal Drugs and Biologics Sales by Type (2019-2024)
4.1.2 Global Retinal Drugs and Biologics Sales by Type (2025-2030)
4.1.3 Global Retinal Drugs and Biologics Sales Market Share by Type (2019-2030)
4.2 Global Retinal Drugs and Biologics Revenue by Type (2019-2030)
4.2.1 Global Retinal Drugs and Biologics Revenue by Type (2019-2024)
4.2.2 Global Retinal Drugs and Biologics Revenue by Type (2025-2030)
4.2.3 Global Retinal Drugs and Biologics Revenue Market Share by Type (2019-2030)
4.3 Global Retinal Drugs and Biologics Price by Type (2019-2030)
5 Segment by Application
5.1 Global Retinal Drugs and Biologics Sales by Application (2019-2030)
5.1.1 Global Retinal Drugs and Biologics Sales by Application (2019-2024)
5.1.2 Global Retinal Drugs and Biologics Sales by Application (2025-2030)
5.1.3 Global Retinal Drugs and Biologics Sales Market Share by Application (2019-2030)
5.2 Global Retinal Drugs and Biologics Revenue by Application (2019-2030)
5.2.1 Global Retinal Drugs and Biologics Revenue by Application (2019-2024)
5.2.2 Global Retinal Drugs and Biologics Revenue by Application (2025-2030)
5.2.3 Global Retinal Drugs and Biologics Revenue Market Share by Application (2019-2030)
5.3 Global Retinal Drugs and Biologics Price by Application (2019-2030)
6 Key Companies Profiled
6.1 ALLERGAN
6.1.1 ALLERGAN Corporation Information
6.1.2 ALLERGAN Description and Business Overview
6.1.3 ALLERGAN Retinal Drugs and Biologics Sales, Revenue and Gross Margin (2019-2024)
6.1.4 ALLERGAN Retinal Drugs and Biologics Product Portfolio
6.1.5 ALLERGAN Recent Developments/Updates
6.2 AbbVie
6.2.1 AbbVie Corporation Information
6.2.2 AbbVie Description and Business Overview
6.2.3 AbbVie Retinal Drugs and Biologics Sales, Revenue and Gross Margin (2019-2024)
6.2.4 AbbVie Retinal Drugs and Biologics Product Portfolio
6.2.5 AbbVie Recent Developments/Updates
6.3 Alimera Sciences
6.3.1 Alimera Sciences Corporation Information
6.3.2 Alimera Sciences Description and Business Overview
6.3.3 Alimera Sciences Retinal Drugs and Biologics Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Alimera Sciences Retinal Drugs and Biologics Product Portfolio
6.3.5 Alimera Sciences Recent Developments/Updates
6.4 Janssen Biotech
6.4.1 Janssen Biotech Corporation Information
6.4.2 Janssen Biotech Description and Business Overview
6.4.3 Janssen Biotech Retinal Drugs and Biologics Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Janssen Biotech Retinal Drugs and Biologics Product Portfolio
6.4.5 Janssen Biotech Recent Developments/Updates
6.5 Swedish Orphan Biovitrum
6.5.1 Swedish Orphan Biovitrum Corporation Information
6.5.2 Swedish Orphan Biovitrum Description and Business Overview
6.5.3 Swedish Orphan Biovitrum Retinal Drugs and Biologics Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Swedish Orphan Biovitrum Retinal Drugs and Biologics Product Portfolio
6.5.5 Swedish Orphan Biovitrum Recent Developments/Updates
6.6 Roche
6.6.1 Roche Corporation Information
6.6.2 Roche Description and Business Overview
6.6.3 Roche Retinal Drugs and Biologics Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Roche Retinal Drugs and Biologics Product Portfolio
6.6.5 Roche Recent Developments/Updates
6.7 Bristol-Myers Squibb
6.6.1 Bristol-Myers Squibb Corporation Information
6.6.2 Bristol-Myers Squibb Description and Business Overview
6.6.3 Bristol-Myers Squibb Retinal Drugs and Biologics Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Bristol-Myers Squibb Retinal Drugs and Biologics Product Portfolio
6.7.5 Bristol-Myers Squibb Recent Developments/Updates
6.8 Genzyme
6.8.1 Genzyme Corporation Information
6.8.2 Genzyme Description and Business Overview
6.8.3 Genzyme Retinal Drugs and Biologics Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Genzyme Retinal Drugs and Biologics Product Portfolio
6.8.5 Genzyme Recent Developments/Updates
6.9 Genentech
6.9.1 Genentech Corporation Information
6.9.2 Genentech Description and Business Overview
6.9.3 Genentech Retinal Drugs and Biologics Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Genentech Retinal Drugs and Biologics Product Portfolio
6.9.5 Genentech Recent Developments/Updates
6.10 OCULAR THERAPEUTIX
6.10.1 OCULAR THERAPEUTIX Corporation Information
6.10.2 OCULAR THERAPEUTIX Description and Business Overview
6.10.3 OCULAR THERAPEUTIX Retinal Drugs and Biologics Sales, Revenue and Gross Margin (2019-2024)
6.10.4 OCULAR THERAPEUTIX Retinal Drugs and Biologics Product Portfolio
6.10.5 OCULAR THERAPEUTIX Recent Developments/Updates
6.11 Bausch & Lomb
6.11.1 Bausch & Lomb Corporation Information
6.11.2 Bausch & Lomb Retinal Drugs and Biologics Description and Business Overview
6.11.3 Bausch & Lomb Retinal Drugs and Biologics Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Bausch & Lomb Retinal Drugs and Biologics Product Portfolio
6.11.5 Bausch & Lomb Recent Developments/Updates
6.12 UCBCares
6.12.1 UCBCares Corporation Information
6.12.2 UCBCares Retinal Drugs and Biologics Description and Business Overview
6.12.3 UCBCares Retinal Drugs and Biologics Sales, Revenue and Gross Margin (2019-2024)
6.12.4 UCBCares Retinal Drugs and Biologics Product Portfolio
6.12.5 UCBCares Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Retinal Drugs and Biologics Industry Chain Analysis
7.2 Retinal Drugs and Biologics Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Retinal Drugs and Biologics Production Mode & Process
7.4 Retinal Drugs and Biologics Sales and Marketing
7.4.1 Retinal Drugs and Biologics Sales Channels
7.4.2 Retinal Drugs and Biologics Distributors
7.5 Retinal Drugs and Biologics Customers
8 Retinal Drugs and Biologics Market Dynamics
8.1 Retinal Drugs and Biologics Industry Trends
8.2 Retinal Drugs and Biologics Market Drivers
8.3 Retinal Drugs and Biologics Market Challenges
8.4 Retinal Drugs and Biologics Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer